drugset / Trial / NCT02918123
Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis
NaSingle-groupOpen-labelTreatment
Summary
Phase I clinical trial to evaluate safety of FURESTEM-CD Inj. in patients with moderate to severe in plaque-type psoriasis injection for 4weeks.
Timeline
- Start
- 2018-01-17
- Primary completion
- 2021-12
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FURESTEM-CD | Cell therapy | 1e+07 cells | Subcutaneous |
| Subject | FURESTEM-CD | Cell therapy | 5e+07 cells | Subcutaneous |
| Subject | FURESTEM-CD | Cell therapy | 2e+08 cells | Subcutaneous |